Predicting Individual Survival After Gastric Cancer Resection: Validation of a U.S.-Derived Nomogram at a Single High-Volume Center in Europe
暂无分享,去创建一个
[1] D. Cunningham,et al. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) , 2005 .
[2] H. Medina-Franco,et al. Clinicopathologic characteristics of gastric cancer in a young patient population , 2004, Journal of Gastrointestinal Surgery.
[3] M. Kattan,et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Feinglass,et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. , 2003, Surgery.
[5] S. Kim,et al. Clinicopathological characteristics of gastric carcinoma in young patients , 2003, Langenbeck's Archives of Surgery.
[6] H. Lee,et al. Tumour suppressor gene expression correlates with gastric cancer prognosis , 2003, The Journal of pathology.
[7] S. Kitano,et al. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer , 2002, Annals of Surgical Oncology.
[8] Aller,et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.
[9] A. Kokkola,et al. Gastric carcinoma in young adults. , 2001, Hepato-gastroenterology.
[10] H. Lee,et al. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas , 2001, Cancer.
[11] H. Frierson,et al. Expression profiling of gastric adenocarcinoma using cDNA array , 2001, International journal of cancer.
[12] R. Mazzanti,et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up , 2001, British Journal of Cancer.
[13] M. Brennan,et al. Gastric Cancer in Young Patients: Demographic, Clinicopathological, and Prognostic Factors in 92 Patients , 2000, Annals of Surgical Oncology.
[14] K. Höffken,et al. Gastric cancer in very young adults: apropos four patients and a review of the literature , 2000, Journal of Cancer Research and Clinical Oncology.
[15] I. Tusquets,et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. Tsuneyoshi,et al. A clinicopathological study in young patients with gastric carcinoma , 1999, Journal of surgical oncology.
[17] X. Hao,et al. [Gastric cancer in the young]. , 1999, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[18] C. Earle,et al. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. , 1999, European journal of cancer.
[19] T. Ichikura,et al. Prognostic impact of stromal cell‐derived urokinase–type plasminogen activator in gastric carcinoma , 1999, Cancer.
[20] H. Nekarda,et al. Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma , 1999, British Journal of Cancer.
[21] J. Siewert,et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.
[22] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[23] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[24] M. Brennan,et al. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. , 1997, Annals of surgery.
[25] J. Siewert,et al. Lymphadenektomie bei Tumoren des oberen Gastrointestinaltraktes , 1996, Der Chirurg.
[26] M. Feith,et al. [Lymphadenectomy with tumors of the upper gastrointestinal tract]. , 1996, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[27] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[28] H. Höfler,et al. Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. , 1995, The American journal of pathology.
[29] H. Yokozaki,et al. Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.
[30] H. Inoue,et al. Microsatellite instability in Japanese gastric cancer , 1995, Cancer.
[31] R. Lothe,et al. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile , 1995, International journal of cancer.
[32] K. Becker,et al. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. , 1994, Cancer research.
[33] K. Becker,et al. [Prognostic factors in stomach cancer. Results of a uni- and multivariate analysis]. , 1992, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[34] M. Rothmund,et al. Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer , 1991, The British journal of surgery.
[35] Takuma Sasaki,et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. , 1991, Cancer research.
[36] K. Sugimachi,et al. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. , 1989, Archives of surgery.
[37] K. Sugimachi,et al. DNA ploidy and tumor invasion in human gastric cancer. Histopathologic differentiation. , 1989, Archives of surgery.
[38] M. Brennan,et al. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. , 1989, Hepato-gastroenterology.
[39] T. Nakajima,et al. [Prognostic factors in gastric cancer]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.
[40] S. Andreola,et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. , 1986, Surgery, gynecology & obstetrics.
[41] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[42] Tanaki Kajitani,et al. The general rules for the gastric cancer study in surgery and pathology , 1981, The Japanese journal of surgery.
[43] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[44] S. Msika,et al. Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: A multivariate analysis , 2005, World Journal of Surgery.
[45] M. Heslin,et al. Clinicopathological Characteristics of Gastric Carcinoma in Young and Elderly Patients: A Comparative Study , 2000, Annals of Surgical Oncology.
[46] M. Noguchi. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. , 1997, The British journal of surgery.
[47] S. Hirohashi,et al. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. , 1993, Cancer.
[48] Siewert,et al. [Cardia cancer: attempt at a therapeutically relevant classification]. , 1987, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[49] K. Maruyama. The Most Important Prognostic Factors for Gastric Cancer Patients: A Study Using Univariate and Multivariate Analyses , 1987 .